Molecular imaging of biomarkers in breast cancer Journal Article
| Authors: | Ulaner, G. A.; Riedl, C. C.; Dickler, M. N.; Jhaveri, K.; Pandit-Taskar, N.; Weber, W. |
| Article Title: | Molecular imaging of biomarkers in breast cancer |
| Abstract: | The success of breast cancer therapy is ultimately defined by clinical endpoints such as survival. It is valuable to have biomarkers that can predict the most efficacious therapies or measure response to therapy early in the course of treatment. Molecular imaging has a promising role in complementing and overcoming some of the limitations of traditional biomarkers by providing the ability to perform noninvasive, repeatable whole-body assessments. The potential advantages of imaging biomarkers are obvious and initial clinical studies have been promising, but proof of clinical utility still requires prospective multicenter clinical trials.. Copyright © 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc. |
| Keywords: | biomarkers; breast cancer; breast; molecular imaging; oncology; pet/ct; 18f-fdg |
| Journal Title: | Journal of Nuclear Medicine |
| Volume: | 57 |
| Issue: | Suppl. 1 |
| ISSN: | 0161-5505 |
| Publisher: | Society of Nuclear Medicine |
| Date Published: | 2016-02-01 |
| Start Page: | 53S |
| End Page: | 59S |
| Language: | English |
| DOI: | 10.2967/jnumed.115.157909 |
| PROVIDER: | scopus |
| PUBMED: | 26834103 |
| PMCID: | PMC4979972 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 3 March 2016 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work